Yahoo Finance • 6 days ago
NEW YORK, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story
Yahoo Finance • 6 days ago
Baron Funds, an investment management company, released its “Baron Discovery Fund” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. The Fund focuses on long-term, competitively positioned companies that are... Full story
Yahoo Finance • 7 days ago
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Abbott Laboratories (NYSE:ABT) agreed to acquire Exact Sciences for US$21b. The deal is set to r... Full story
Yahoo Finance • last month
[Wall Street New York Stock Exchange Stock Market & Government Tariffs] Douglas Rissing Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may i... Full story
Yahoo Finance • 2 months ago
This article first appeared on GuruFocus. Exploring the Fund's Recent Portfolio Adjustments Vanguard Health Care Fund (Trades, Portfolio) recently submitted its N-PORT filing for the third quarter of 2025, shedding light on its strategic... Full story
Yahoo Finance • 2 months ago
[Futuristic display screen with a bar graph and colorful spreadsheet financial data] matejmo Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that... Full story
Yahoo Finance • 2 months ago
Exact Sciences stock now sits at the center of a tightening deal spread, with our fair value estimate holding steady near $103.67 per share. This closely tracks the proposed $105 takeout price even as the discount rate edges up to 7.27 and... Full story
Yahoo Finance • 2 months ago
Below is Validea's guru fundamental report for EXACT SCIENCES CORP (EXAS). Of the 22 guru strategies we follow, EXAS rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model l... Full story
Yahoo Finance • 2 months ago
If you have been wondering whether Exact Sciences is still worth buying after its huge run, you are not alone. This breakdown is designed to help you decide if the current price makes sense. The stock has climbed to around $101.06, logging... Full story
Yahoo Finance • 2 months ago
We came across a bullish thesis on Bio-Techne Corporation on Valueinvestorsclub.com by rab. In this article, we will summarize the bulls’ thesis on TECH. Bio-Techne Corporation's share was trading at $64.63 as of November 26th. TECH’s trai... Full story
Yahoo Finance • 2 months ago
Key Points Early cancer detection is highly beneficial to sufferers, and Grail's Galleri test offers a solution. The company is the leader in the race for FDA approval, but it could benefit from being part of a larger company. Commercial... Full story
Yahoo Finance • 2 months ago
Cathie Wood’s never been shy in rebalancing aggressively when she feels the market’s mispricing innovation, and her latest trades fit that description perfectly. The ARK Invest boss dumped nearly 855,000 GitLab (GTLB) stock in just a few... Full story
Yahoo Finance • 2 months ago
[Investment. Businessman using laptop and analyzing data with investment growth on stock markets, startups, real estate, technology, and financial trends on global network.] Harsa Maduranga/iStock via Getty Images Cathie Wood’s ARK Invest... Full story
Yahoo Finance • 2 months ago
Abbott Laboratories (NYSE:ABT) ranks among the best slow growth stocks to invest in. UBS reaffirmed its Buy rating and $158 price target for Abbott Laboratories (NYSE:ABT) on November 21 in response to the company’s agreed acquisition of E... Full story
Yahoo Finance • 2 months ago
NEW YORK, Nov. 27, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story
Yahoo Finance • 2 months ago
NEW YORK, Nov. 27, 2025 (GLOBE NEWSWIRE) -- We wish you a Happy Thanksgiving and Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), who has recovered millions of dollars for shareholders... Full story
Yahoo Finance • 2 months ago
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: UBS upgraded Applied Materials(AMAT) t... Full story
Yahoo Finance • 2 months ago
Chaay_Tee / iStock via Getty Images Quick Read The markets stormed back on Monday after a late Friday reversal, which was a big positive for traders. All the major indices rose on Monday, and concerns about a big Thanksgiving sell-off di... Full story
Yahoo Finance • 3 months ago
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Wedbush upgraded Carvana (CVNA) to Out... Full story
Yahoo Finance • 3 months ago
MONSEY, N.Y., Nov. 24, 2025 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of Exact Sciences Corporation (Nasdaq: EXAS) (“Exact Sciences”) to Abbott Laboratories for $105.00 per... Full story